Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Janine Spreuer"'
Autor:
Teresa Amaral, Benjamin Weide, Graham Pawelec, Thomas Eigentler, Claus Garbe, Patrick Terheyden, Friedegund Meier, Kilian Wistuba-Hamprecht, Alexander Martens, Jonas Bochem, Janine Spreuer, Andrea Gaissler, Shannon Ottmann, Nikolaus Benjamin Wagner, Manfred Claassen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background The need for reliable clinical biomarkers to predict which patients with melanoma will benefit from immune checkpoint blockade (ICB) remains unmet. Several different parameters have been considered in the past, including routine differenti
Externí odkaz:
https://doaj.org/article/521aee0a376b4390b6c381956eae52b4
Autor:
Andrea Gaißler, Trine Sundebo Meldgaard, Christina Heeke, Sepideh Babaei, Siri Amanda Tvingsholm, Jonas Bochem, Janine Spreuer, Teresa Amaral, Nikolaus Benjamin Wagner, Reinhild Klein, Friedegund Meier, Claus Garbe, Thomas K. Eigentler, Graham Pawelec, Manfred Claassen, Benjamin Weide, Sine Reker Hadrup, Kilian Wistuba-Hamprecht
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Immune checkpoint blockade (ICB) is standard-of-care for patients with metastatic melanoma. It may re-invigorate T cells recognizing tumors, and several tumor antigens have been identified as potential targets. However, little is known about the dyna
Externí odkaz:
https://doaj.org/article/dc14c7a742f64dffb8f851c85b32709c
Autor:
Thomas K Eigentler, Teresa Amaral, Benjamin Weide, Graham Pawelec, Tobias Sinnberg, Claus Garbe, Lukas Flatz, Friedegund Meier, Kilian Wistuba-Hamprecht, Alfred Königsrainer, Oltin T Pop, Jonas Bochem, Henning Zelba, Janine Spreuer, Andrea Gaissler, Karolin Thiel, Can Yurttas, Daniel Soffel, Stephan Forchhammer, Heike Niessner, Markus W Löffler
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 12 (2021)
Externí odkaz:
https://doaj.org/article/ae54a7ec886d4fc992af361601f875fa
Autor:
Jonas Bochem, Henning Zelba, Teresa Amaral, Janine Spreuer, Daniel Soffel, Thomas Eigentler, Nikolaus Benjamin Wagner, Ugur Uslu, Patrick Terheyden, Friedegund Meier, Claus Garbe, Graham Pawelec, Benjamin Weide, Kilian Wistuba-Hamprecht
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221301 (2019)
Immune checkpoint blockade with anti-PD-1 antibodies is showing great promise for patients with metastatic melanoma and other malignancies, but despite good responses by some patients who achieve partial or complete regression, many others still do n
Externí odkaz:
https://doaj.org/article/1b7279ec42ea43559896db648792ada4